CODX - CIK 0001692415
Co-Diagnostics, Inc. (CODX) reported revenue of $622.49K for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $622.49K | -84.1% |
| FY 2024 | $3.92M | -42.5% |
| FY 2023 | $6.81M | -80.1% |
| FY 2022 | $34.22M | -65.0% |
| FY 2021 | $97.89M | +31.3% |
| FY 2020 | $74.55M | +34579.9% |
| FY 2019 | $214.97K | +438.6% |
| FY 2018 | $39.91K | +420.9% |
| FY 2017 |
Co-Diagnostics, Inc. (CODX) reported revenue of $622.49K for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Co-Diagnostics, Inc.'s revenue grew from $7.66K to $622.49K.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.66K |
| - |